Boehringer Ingelheim enrols first patient in TOviTO Phase III clinical trial program
- Details
- Category: Boehringer Ingelheim

Bristol-Myers Squibb and Ambrx Announce Collaboration
- Details
- Category: Bristol-Myers Squibb

Sanofi Pasteur Donates Vaccine Strain Used for Polio Eradication to WHO
- Details
- Category: Sanofi

Bristol-Myers Squibb and Ono Enter into Strategic Agreement
- Details
- Category: Bristol-Myers Squibb

Novartis associates participate in first company-wide health and well-being initiative
- Details
- Category: Novartis

Prolia® (Denosumab) Phase 2 Extension Study
- Details
- Category: Amgen

Merck Statement on GARDASIL®
- Details
- Category: Merck

More Pharma News ...
- Lilly Invests $30 Million in Partnership to Address Non-Communicable Diseases
- Boehringer Ingelheim and EFSD collaborate to support diabetes research in Europe
- Novartis increases growth potential through integration of Alcon
- Initiation of Lantus leads to better glycemic control at similar weight gain
- Roche named Dow Jones Sustainability Index leader in healthcare for third consecutive year
- Bristol-Myers Squibb Completes Acquisition of Amira Pharmaceuticals
- GSK awarded contract by BARDA to support research on potential novel antibiotic